Search Editorial Photos
"Phase 3 Study"
63 professional editorial images found
#6198148
19 November 2020
A medical syringe and vials in front of the US flag are seen in this creative photo taken on 18 November 2020. Pfizer and Biontech announced its conclude phase 3 study of COVID-19 coronavirus vaccine candidate with 95% primary efficacy analysis, as media reported on 18 November 2020.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6198152
19 November 2020
A medical syringe and vials in front of the U.S. flag are seen in this creative photo taken on 18 November 2020. Pfizer and Biontech announced its conclude phase 3 study of COVID-19 coronavirus vaccine candidate with 95% primary efficacy analysis, as media reported on 18 November 2020.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6198154
19 November 2020
A medical syringe and a vial in front of the U.S. flag are seen in this creative photo taken on 18 November 2020. Pfizer and Biontech announced its conclude phase 3 study of COVID-19 coronavirus vaccine candidate with 95% primary efficacy analysis, as media reported on 18 November 2020.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6198156
19 November 2020
A medical syringe and a vial in front of the US flag are seen in this creative photo taken on 18 November 2020. Pfizer and Biontech announced its conclude phase 3 study of COVID-19 coronavirus vaccine candidate with 95% primary efficacy analysis, as media reported on 18 November 2020.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6198158
19 November 2020
A medical syringe and a vial in front of the U.S. flag are seen in this creative photo taken on 18 November 2020. Pfizer and Biontech announced its conclude phase 3 study of COVID-19 coronavirus vaccine candidate with 95% primary efficacy analysis, as media reported on 18 November 2020.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6198162
19 November 2020
A medical syringe in front of the flag of China is seen in this creative photo taken on 18 November 2020. Pfizer and Biontech announced its conclude phase 3 study of COVID-19 coronavirus vaccine candidate with 95% primary efficacy analysis, as media reported on 18 November 2020.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6198006
19 November 2020
A medical syringe in front of the Pfizer US pharmaceutical corporation logo is seen in this creative photo taken on 18 November 2020. Pfizer and Biontech announced its conclude phase 3 study of COVID-19 vaccine candidate with 95% primary efficacy analysis, as the media reported on 18 November 2020.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6198008
19 November 2020
A medical syringe in front of the Pfizer US pharmaceutical corporation logo is seen in this creative photo taken on 18 November 2020. Pfizer and Biontech announced its conclude phase 3 study of COVID-19 vaccine candidate with 95% primary efficacy analysis, as the media reported on 18 November 2020.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6198010
19 November 2020
A medical syringe and a vial in front of the Pfizer US pharmaceutical corporation logo are seen in this creative photo taken on 18 November 2020. Pfizer and Biontech announced its conclude phase 3 study of COVID-19 vaccine candidate with 95% primary efficacy analysis, as the media reported on 18 November 2020.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6198012
19 November 2020
Vials in front of the Pfizer US pharmaceutical corporation logo are seen in this creative photo taken on 18 November 2020. Pfizer and Biontech announced its conclude phase 3 study of COVID-19 vaccine candidate with 95% primary efficacy analysis, as the media reported on 18 November 2020.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6198014
19 November 2020
A medical syringe and vials in front of the Pfizer US pharmaceutical corporation and Biontech German biotechnology company logos are seen in this creative photo taken on 18 November 2020. Pfizer and Biontech announced its conclude phase 3 study of COVID-19 vaccine candidate with 95% primary efficacy analysis, as the media reported on 18 November 2020.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6198016
19 November 2020
A medical syringe and vials in front of the Pfizer US pharmaceutical corporation and Biontech German biotechnology company logos are seen in this creative photo taken on 18 November 2020. Pfizer and Biontech announced its conclude phase 3 study of COVID-19 vaccine candidate with 95% primary efficacy analysis, as the media reported on 18 November 2020.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6198018
19 November 2020
A medical syringe in front of the Pfizer US pharmaceutical corporation and Biontech German biotechnology company logos is seen in this creative photo taken on 18 November 2020. Pfizer and Biontech announced its conclude phase 3 study of COVID-19 vaccine candidate with 95% primary efficacy analysis, as the media reported on 18 November 2020.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6198020
19 November 2020
A medical syringe and vials in front of the Pfizer US pharmaceutical corporation and Biontech German biotechnology company logos are seen in this creative photo taken on 18 November 2020. Pfizer and Biontech announced its conclude phase 3 study of COVID-19 vaccine candidate with 95% primary efficacy analysis, as the media reported on 18 November 2020.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6198022
19 November 2020
A medical syringe and a vial in front of the Pfizer US pharmaceutical corporation and Biontech German biotechnology company logos are seen in this creative photo taken on 18 November 2020. Pfizer and Biontech announced its conclude phase 3 study of COVID-19 vaccine candidate with 95% primary efficacy analysis, as the media reported on 18 November 2020.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6198024
19 November 2020
A medical syringe and vials in front of the Biontech German biotechnology company logo are seen in this creative photo taken on 18 November 2020. Pfizer and Biontech announced its conclude phase 3 study of COVID-19 vaccine candidate with 95% primary efficacy analysis, as the media reported on 18 November 2020.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.